- Home
- LDWY vs BDRX Comparison
LDWY vs BDRX Comparison
Compare LDWY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- BDRX
- Stock Information
- Founded
- LDWY 1990
- BDRX 2000
- Country
- LDWY United States
- BDRX United Kingdom
- Employees
- LDWY N/A
- BDRX N/A
- Industry
- LDWY Advertising
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- BDRX Health Care
- Exchange
- LDWY Nasdaq
- BDRX Nasdaq
- Market Cap
- LDWY 6.7M
- BDRX 2.8M
- IPO Year
- LDWY 1991
- BDRX N/A
- Fundamental
- Price
- LDWY $3.42
- BDRX $6.15
- Analyst Decision
- LDWY
- BDRX Strong Buy
- Analyst Count
- LDWY 0
- BDRX 1
- Target Price
- LDWY N/A
- BDRX $200.00
- AVG Volume (30 Days)
- LDWY 9.9K
- BDRX 457.8K
- Earning Date
- LDWY 11-11-2024
- BDRX 10-29-2024
- Dividend Yield
- LDWY N/A
- BDRX N/A
- EPS Growth
- LDWY N/A
- BDRX N/A
- EPS
- LDWY N/A
- BDRX N/A
- Revenue
- LDWY $24,813,000.00
- BDRX $104,895.00
- Revenue This Year
- LDWY N/A
- BDRX N/A
- Revenue Next Year
- LDWY N/A
- BDRX N/A
- P/E Ratio
- LDWY N/A
- BDRX N/A
- Revenue Growth
- LDWY N/A
- BDRX N/A
- 52 Week Low
- LDWY $3.02
- BDRX $4.71
- 52 Week High
- LDWY $6.88
- BDRX $220.25
- Technical
- Relative Strength Index (RSI)
- LDWY 46.04
- BDRX 43.80
- Support Level
- LDWY $3.34
- BDRX $5.50
- Resistance Level
- LDWY $3.66
- BDRX $10.89
- Average True Range (ATR)
- LDWY 0.20
- BDRX 1.07
- MACD
- LDWY 0.04
- BDRX 0.32
- Stochastic Oscillator
- LDWY 62.50
- BDRX 23.30
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.